![]() |
The UK approved the use of a new drug to treat people at high risk of developing severe symptoms of COVID-19, which the manufacturer reported showed encouraging results against the new variant Omicron. Antibody treatment, sotrovimab, “It was found to ... Medicines and Healthcare products Regulatory Agency, Monoclonal antibody therapy, United Kingdom |
||
More about this | |||
|
|||
|